|Articles|April 26, 2017

Survey: When It Comes to Preventing HAIs, Where Should We Turn Our Attention?

Do some healthcare-associated infections receive more attention at your institution than others? Has your institution committed to using single-use medical devices to stave off infections? The editorial staff at Contagion® wants your feedback. Please take this brief survey to weigh-in.

Survey: Where Does Your Institution Focus Its Infection Prevention Efforts?

Healthcare-associated infection (HAI) prevention programs and efforts are continually changing, and the editorial staff at Contagion® reports on these changes daily. But more importantly, you, the practitioner, see these changes happening in real-time in your hospitals, and acute and long-term care facilities.

As new research reveals more information about the pathogens that cause these potentially deadly infections, new infection prevention techniques come to light, and old practices are sometimes questioned. From the use of ultraviolet light machines to destroy superbugs in hospital rooms, and examining the limitations of contact precautions for patients with methicillin-resistant Staphylococcus aureus, to the increased use of disposable medical devices, the landscape of infection prevention methods is constantly evolving.

Although senior leadership in your organization may be responsible for the decision-making process on many of the infection prevention methods followed at your institution, you are the one responsible for enacting and performing these practices. As such, we at Contagion® want to know what practices you are using “in the trenches,” and which infections your institutions focus on most.

That’s why we created this brief poll. Completing this poll will not only provide us with greater insight about which infection prevention practices are followed at your institution, but it will also help us as we continue to shape our future editorial direction.

Our goal is to make Contagion® as useful as possible, to you, the practitioner. Taking this survey will help us gauge which topics matter most to our audience.

You can take the survey here.


Related to this article

Ebola Outbreak Tops 10,000 Cases as CDC Cites Spread to Kenya, Nigeria
The CDC reports the Bundibugyo virus outbreak in the Democratic Republic of the Congo (DRC) is now the second-largest Ebola outbreak on record. As of October 28, the agency counted 10,305 total confirmed cases and 4,996 total confirmed deaths. The overall risk to the American public and travelers remains low, and no cases tied to this outbreak have been confirmed in the US.
Measles Update: October 30, 2026
The latest CDC numbers show a 5.8% increase in measles cases from week-to-week, bringing the 2026 US total to more than double the amount seen in all of 2025 with 2 months left in the year.
Cefiderocol Continues to Show Activity Against Resistant Gram-Negative Infections
Shionogi data presented at IDWeek 2026 demonstrated a 76.7% clinical response with cefiderocol in carbapenem-resistant respiratory infections and high in vitro activity against resistant P aeruginosa VAP isolates. Christine Slover, PharmD, vice president, Infectious Diseases US Medical Affairs, Shionogi, offers insights on the data as well as clinical considerations for providers when weighing the antibiotic for patients.